Hovione
PrivateLast Round
Debt
Apr 24, 2026
Total Funding Raised
$144.4M
Company Overview
Hovione is a pharmaceutical company that operates as a Contract Development and Manufacturing Organization (CDMO), providing services for drug substance, drug product intermediate, and drug product development and manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hovione Comps
Public and private peers based on sector, stage, and business model.
Hovione Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 24, 2026 | ||||
| Debt | May 31, 2024 | ||||
| Debt | Jan 25, 2019 | ||||
| Debt | May 6, 2002 |
Hovione Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Bank Group | Debt |
| Banco BPI | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
$30M debt round completed.
- May 31, 2024
$59.4M debt round completed.
Hovione Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hovione's valuation, stock price, and market status.
